Risk of Sudden Cardiac Arrest Tripled for Young Women After Receiving AstraZeneca COVID-19 Vaccine

The UK’s Office for National Statistics (ONS) senior statistician Vahé Nafilyan said research has found “receiving a first dose of a non-mRNA vaccine was associated with an increased risk of cardiac death in young women.”

Researchers compared deaths of those between 12 and 29 years old that occurred within 12 weeks of COVID-19 vaccination to the deaths that occurred at any point after 12 weeks.

The data showed that cardiac arrest among young women was three times greater in the 12 weeks following vaccination from a non-mRNA vaccine.

From The Epoch Times:

“The findings are somewhat unexpected, as concerns about rare cardiac side-effects—specifically myocarditis and pericarditis—have hitherto been particularly associated with mRNA vaccine second doses in males especially when the dose interval was short, whereas the signal reported here is primarily in non-mRNA first doses in females,” [Professor of paediatrics at the University of Bristol and a member of the UK’s Joint Committee on Vaccination and Immunisation Adam Finn] said in a statement.

He said the overall data seems “reassuring,” and the increased mortality associated with a positive COVID-19 test result “raises the question whether the spike protein—which is expressed both during infection and following vaccination—is the cause.”

“The next and most pressing issue that needs to be addressed is to gather more detailed information on what the nature of the reported cardiac events actually was, as this would help us begin to understand what is really being seen in these figures and might help guide future policy and vaccine design,” he added.